Evidence map›Paper›PMID 35653606›Full record

ArticleJournal of medical Internet research2022

Exploring Longitudinal Cough, Breath, and Voice Data for COVID-19 Progression Prediction via Sequential Deep Learning: Model Development and Validation.

Ting Dang, Jing Han, Tong Xia, Dimitris Spathis, Erika Bondareva, Chloë Siegele-Brown, Jagmohan Chauhan, Andreas Grammenos, Apinan Hasthanasombat, R Andres Floto and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ting DangDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-3806-1493
Jing Han *Department of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-5776-6849
Tong Xia *Department of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-6994-6318
Dimitris SpathisDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9761-951X
Erika BondarevaDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2046-3278
Chloë Siegele-BrownDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-9229-3351
Jagmohan ChauhanDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-2080-3276
Andreas GrammenosDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2525-5101
Apinan HasthanasombatDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-8054-9885
R Andres FlotoDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2188-5659
Pietro CicutaDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-9193-8496
Cecilia MascoloDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9614-4380
University of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent work has shown the potential of using audio data (eg, cough, breathing, and voice) in the screening for COVID-19. However, these approaches only focus on one-off detection and detect the infection, given the current audio sample, but do not monitor disease progression in COVID-19. Limited exploration has been put forward to continuously monitor COVID-19 progression, especially recovery, through longitudinal audio data. Tracking disease progression characteristics and patterns of recovery could bring insights and lead to more timely treatment or treatment adjustment, as well as better resource management in health care systems.

objectiveThe primary objective of this study is to explore the potential of longitudinal audio samples over time for COVID-19 progression prediction and, especially, recovery trend prediction using sequential deep learning techniques.

methodsCrowdsourced respiratory audio data, including breathing, cough, and voice samples, from 212 individuals over 5-385 days were analyzed, alongside their self-reported COVID-19 test results. We developed and validated a deep learning-enabled tracking tool using gated recurrent units (GRUs) to detect COVID-19 progression by exploring the audio dynamics of the individuals' historical audio biomarkers. The investigation comprised 2 parts: (1) COVID-19 detection in terms of positive and negative (healthy) tests using sequential audio signals, which was primarily assessed in terms of the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity, with 95% CIs, and (2) longitudinal disease progression prediction over time in terms of probability of positive tests, which was evaluated using the correlation between the predicted probability trajectory and self-reported labels.

resultsWe first explored the benefits of capturing longitudinal dynamics of audio biomarkers for COVID-19 detection. The strong performance, yielding an AUROC of 0.79, a sensitivity of 0.75, and a specificity of 0.71 supported the effectiveness of the approach compared to methods that do not leverage longitudinal dynamics. We further examined the predicted disease progression trajectory, which displayed high consistency with longitudinal test results with a correlation of 0.75 in the test cohort and 0.86 in a subset of the test cohort with 12 (57.1%) of 21 COVID-19-positive participants who reported disease recovery. Our findings suggest that monitoring COVID-19 evolution via longitudinal audio data has potential in the tracking of individuals' disease progression and recovery.

conclusionsAn audio-based COVID-19 progression monitoring system was developed using deep learning techniques, with strong performance showing high consistency between the predicted trajectory and the test results over time, especially for recovery trend predictions. This has good potential in the postpeak and postpandemic era that can help guide medical treatment and optimize hospital resource allocations. The changes in longitudinal audio samples, referred to as audio dynamics, are associated with COVID-19 progression; thus, modeling the audio dynamics can potentially capture the underlying disease progression process and further aid COVID-19 progression prediction. This framework provides a flexible, affordable, and timely tool for COVID-19 tracking, and more importantly, it also provides a proof of concept of how telemonitoring could be applicable to respiratory diseases monitoring, in general.

Indexed as

COVID-19Deep LearningVoiceCoughDisease ProgressionHumansaudioCOVID-19COVID-19 progressiondeep learninglongitudinal studymobile health

Identifiers

PMID35653606
PMCPMC9217153
OpenAlexW4281802538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.